| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
Honokiol
|
35354-74-6 |
和厚朴酚
|
和厚朴酚,≥98% ;NSC 293100;NSC293100;NSC-293100;超临界萃取厚朴提取物;3’,5-二-2-丙烯基-1,1’-联苯-2,4’-二酚;和厚朴酚;和厚朴酚HPLC检测纯度为98%;3',1'-联苯-2,4'-二酚,和厚朴酚;厚朴酚和厚朴酚标准品
|
C18H18O2 |
266.33 | 609-119-8 |
|
Ellipticine
|
519-23-3 |
椭圆玫瑰树碱
|
椭圆玫瑰树碱溶液;椭圆玫瑰树碱;CCG-36483;CCG36483;CCG 36483;BRN-0221300;BRN0221300;BRN 0221300;DB-052047;K00071;LP00531;LS-133282;NSC 71795;NSC71795;NSC-71795;TCMDC-125546;VZ29809. ELLIPTECINE;ELLIPTICINE;ELLIPTISINE;玫瑰树碱;椭圆玫瑰树碱溶液;5,11-二甲基-6H-吡啶并[4,3-B]咔唑
|
C17H14N2 |
246.31 | 208-264-0 |
|
5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide hydrochloride
|
158681-13-1 |
盐酸利莫那班
|
CS-1821;盐酸利莫那班;5-(4-氯苯基)-1-(2,4-二氯苯基)-4-甲基-N-(1-哌啶基)-1H-吡唑-3-甲酰胺盐酸盐;5-(4-氯苯基)-1-(2,4-二氯苯基)-4-甲基-N-(1-哌啶基)-1H-吡唑-3-甲酰胺单盐酸盐;利莫那班盐酸盐;N-(哌啶-1-基)-5-(4-氯苯基)-1-(2,4-二氯苯基)-4-甲基-1H-吡唑-3-甲酰胺盐酸盐;SR 141716A; SR 151716A;利莫那班D10盐酸
|
C22H21Cl3N4O.ClH |
500.25 | 213-485-0 |
|
LDN-212854
|
1432597-26-6 |
(LDN212854)
|
5-[6-[4-(1-哌嗪基)苯基]吡唑并[1,5-A]嘧啶-3-基]喹啉;BMP INHIBITOR III;LDN212854;LDN 212854;CS-1202
|
C25H22N6 |
406.48238 | 808-898-3 |
|
CID 2011756
|
638156-11-3 |
CID-211756
|
CID-2011756,5-(3-chlorophenyl)-N-(4-(MorpholinoMethyl)phenyl)furan-2-carboxaMide;CID 2011756;CID-2011756, >97%;5-(3-chlorophenyl)-N-(4-(MorpholinoMethyl)phenyl)furan-2-carboxaMide;5-(3-Chlorophenyl)-N-[4-morpholin-4-ymethyl)phenyl]furan-2-carboxamide;5-(3-Chlorophenyl)-N-[4-(4-morpholinylmethyl)phenyl]-2-furancarboxamide;5-(3-Chlorophenyl)-N-[4-(morpholin-4-ylmethyl)phenyl]furan-2-carboxamide;CID-2011756, >=98%
|
C22H21ClN2O3 |
396.86674 | |
|
Fluoxetine-d5 Hydrochloride
|
1173020-43-3 |
氘代盐酸氟西汀
|
盐酸氟西汀-D5;氟西汀-D5 盐酸盐;氘代盐酸氟西汀
|
C17H14ClD5F3NO |
350.817878 | |
|
H-SER-PHE-ARG-ASN-GLY-VAL-GLY-SER-GLY-VAL-LYS-LYS-THR-SER-PHE-ARG-ARG-ALA-LYS-GLN-OH
|
412938-75-1 |
NEUROPEPTIDE S (RAT)
|
NEUROPEPTIDE S (大鼠)
|
C95H160N34O27 |
2210.5 | |
|
NEUROPEPTIDE S (HUMAN)
|
412938-67-1 |
NEUROPEPTIDE S (HUMAN)
|
|
C93H155N31O28S |
2187.48 | |
|
Oltipraz
|
64224-21-1 |
吡噻硫酮
|
奥替普拉;吡噻硫酮 2G;吡噻硫酮;奥替普拉
|
C8H6N2S3 |
226.34 | 264-736-6 |
|
VU 0364770
|
61350-00-3 |
VU 36477
|
VU0364770;VU-0364770;N-(3-氯苯基)吡啶甲酰胺;N-(3-氯苯基)-2-吡啶甲酰胺;VU 0364770 100MG
|
C12H9ClN2O |
232.66566 | |
|
Ispinesib
|
336113-53-2 |
伊斯平斯
|
伊匹尼塞;ISPINESIB;SB-715992;SB715993;伊斯平斯;(抗癌类)伊斯平斯
|
C30H33ClN4O2 |
517.08 | |
|
KU 0060648
|
881375-00-4 |
KU-6648
|
KU0060648;KU 0060648;CS-768
|
C33H35N4O4S |
583.7204 | |
|
Fendiline hydrochloride
|
13636-18-5 |
盐酸芬他林
|
盐酸芬他林
|
C23H26ClN |
351.91 | 237-121-5 |
|
DMOG
|
89464-63-1 |
二甲基乙二酰氨基乙酸
|
DMOG;DIMETHYLOXALLYL GLYCINE;DIMETHYLOXALYLGLYCINE;89464-63-1;METHYL N-[METHOXY(OXO)ACETYL]GLYCINATE;二甲基乙二酰氨基乙酸;METHYL 2-(2-METHOXY-2-OXOETHYLAMINO)-2-OXOACETATE;二甲基草酰甘氨酸;二甲基乙二酰氨基乙酸>98%
|
C6H9NO5 |
175.14 | 200-256-5 |
|
EPPS
|
16052-06-5 |
4-羟乙基哌嗪丙磺酸
|
N-(2-羟乙基)哌嗪-N-2-丙磺酸;4-羟乙基哌嗪丙磺酸(HEPPS);N-(2-羟乙基)哌嗪-N-3-丙磺酸 4-(2-羟乙基)-1-哌嗪丙磺酸;N-2-羟乙基哌嗪-N-3-丙磺酸 10G;3-[4-(羟乙基)-1-哌嗪基]丙磺酸;4-(2-羟乙基)-1-哌嗪丙磺酸;4-(2-羟乙基)-1-哌嗪丙磺酸,≥99.0%(T);4-(2-羟乙基)-1-哌嗪丙磺酸,≥99.5%(T)
|
C9H20N2O4S |
252.33 | 240-198-8 |
|
ISX 9
|
832115-62-5 |
ISX 9
|
ISX-9;ISX 9;NEURONAL DIFFERENTIATION INDUCER III;N-环丙基-5-(噻吩-2-基)异恶唑-3-甲酰胺;CS-1582
|
C11H10N2O2S |
234.2743 | |
|
VU 0357121
|
433967-28-3 |
VU 357121
|
4-丁氧基-N-(2,4-二氟苯基)苯甲酰胺;4-丁氧基-N-(2;4-二氟苯基)苯甲酰胺
|
C17H17F2NO2 |
305.319186 | |
|
GNF-5
|
778277-15-9 |
GNF-5
|
N-(2-羟基乙基)-3-[6-[[4-(三氟甲氧基)苯基]氨基]-4-嘧啶基]苯甲酰胺;CS-1437;GNF 5;GNF5
|
C20H17F3N4O3 |
418.3691896 | 200-256-5 |
|
ICA-069673
|
582323-16-8 |
ICA 69673
|
ICA069673;ICA-069673
|
C11H6ClF2N3O |
269.634646 | |
|
CKI 7 di hydrochloride
|
1177141-67-1 |
CKI-7 DIHYDROCHLORIDE
|
|
C11H14Cl3N3O2S |
358.67176 |
药智官方微信
药智官方微博
